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Knowledge of the physical chemistry of small molecules complexation (the
hetero-association) in aqueous solution is increasingly important in view of the
rapidly emerging branch of supramolecular chemistry dealing with the formation of
heterogeneous polymeric structures having speciﬁc functional roles. In this paper,
the 50-year history of scientiﬁc studies of hetero-association of heterocyclic aromatic
molecules in aqueous solution has been reviewed. Some important correlations of
structural and thermodynamic parameters of complexation have been reported based
on large data-set of hetero-association parameters accumulated to date. The funda-
mental problem of ‘energetic composition’ of π-stacking is extensively discussed.
The review has shown that there are some gaps in our understanding of hetero-
association, which provides a challenge for further studies in this area.
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energetics; structure
Contents PAGE
1. Introduction 2
2. Applications of hetero-association 4
3. Theoretical models of hetero-association 6
3.1. General requirements of a model for hetero-association 6
3.2. Analytical approaches to building hetero-association models 7
3.3. Evolution of non-cooperative models of hetero-association 7
3.4. Current state-of-the-art and future perspective in the modelling of
hetero-association 8
4. Structure and thermodynamics of hetero-association 16
4.1. Hetero-association of derivatives of nucleic acid bases 16
4.2. Hetero-association of aromatic drugs with derivatives of nucleic acid
bases 19
4.3. Hetero-association of aromatic drugs with aromatic interceptor
molecules and hydrotropes 20
4.3.1. Drug-xanthine system 20
4.3.2. Drug-vitamin system 25
*Email: max_evstigneev@mail.ru
© 2014 Taylor & Francis
International Reviews in Physical Chemistry, 2014
http://dx.doi.org/10.1080/0144235X.2014.926151
D
ow
nl
oa
de
d 
by
 [1
34
.11
7.1
0.2
00
] a
t 2
2:1
3 0
5 J
uly
 20
14
 
4.3.3. Drug-chlorophylline system 27
4.4. Hetero-association of aromatic drugs with aromatic mutagens and
antibiotics 28
4.5. Hetero-association in three-component systems 30
4.6. Summary of the structure and thermodynamics of hetero-association 31
5. Energetics of hetero-association 33
5.1. A fundamental problem in the thermodynamic analysis 34
5.2. Analysis of energetics at the level of Gibbs free energy change 34
5.3. Analysis of energetics at the level of enthalpy and entropy change 36
6. ‘White spots’ of hetero-association 36
7. Summary 37
Acknowledgements 39
References 39
1. Introduction
Aromatic compounds constitute an important group of pharmaceutical drugs, exten-
sively utilised in various medicinal applications. Typical examples are the aromatic
anthracycline antibiotics (e.g. daunomycin, doxorubicin, nogalamycin, novantrone
/mitoxantrone), which are effective against solid tumors and leukemia; quinolone antibi-
otics (e.g. norﬂoxacin, oﬂoxacin), which exert a wide spectrum of antibacterial activity;
aromatic vitamins (e.g. riboﬂavin, nicotinamide), which are used as antioxidants in che-
motherapy, and many other aromatic compounds, possessing useful medico-biological
properties [1, 2]. Apart from major pharmaceutical applications, aromatic molecules
have long been used as model systems to provide insight into the physical interactions,
which play an essential role in maintaining the stability of nucleic acids, proteins and
many other systems of chemical and biological interest [3–5]. In addition, aromatic–
aromatic interactions are currently the focus of great interest due to their role in the for-
mation of supramolecular structures and nano-technological applications [5–7].
Aromatic molecules are represented as rigid planar heterocyclic structures, having
an approximately ﬂat chromophore mainly composed of conjugated double bonds
(C=C, C=N etc) with delocalised π-electrons (Figure 1). Complexation of such mole-
cules in solution is often considered in terms of a rigid-body interaction with minor
contributions from conformational effects such as ‘induced ﬁt’ interactions well known
in host-guest chemistry [8] and polyphenol complexations [9, 10]. It enables the com-
plexation of aromatic molecules discussed in this review to be distinguished from other
types of ‘structurally ﬂexible’ aromatic–aromatic interactions extensively reviewed to
date, e.g. [3–5, 8–11]; in addition, this review does not deal with solvent effects on aro-
matic interactions (e.g. [12, 13]) nor the formation of micellar-type aggregates of aro-
matic molecules (e.g. [14]).
Numerous investigations of the behaviour of aromatic molecules in aqueous
solution have shown that for such compounds at pre-micellar concentrations vertical-
stacking interactions (also known as face-to-face stacked orientation) are the most
important resulting in the formation of ‘sandwich’-type aggregates (Figure 2) with more
than two monomers in the general case [6, 15–17]. A distinction is usually made
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Figure 1. Structures of some representative aromatic drug molecules.
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between self-association (interaction of identical molecules, Figure 2(a)) and hetero-
association (interaction of different molecules, Figure 2(b)) [15, 18, 19]. A very speciﬁc
topical case is the self- and hetero-association of engineered aromatic molecules
involving both face-to-face and edge-to-edge interactions [20]. The energies involved in
non-covalent interactions are comparable to those of thermal motion; hence, the com-
plexation of aromatic molecules in solution (also known as aggregation, assembly or
association) is dynamic in nature, existing in a state of constant rapid formation and
disruption of molecular complexes. Although being relatively simple in terms of the
physics of interactions, the hetero-association of aromatic molecules provides an
excellent template to provide insight into the structure, thermodynamics and energetics
of such fundamental and naturally existing molecular constructions as π-stacking.
The self-association of aromatic molecules has been extensively reviewed and vari-
ous physico-chemical aspects of this process may be considered to be relatively well
investigated. The last comprehensive state-of-the-art review on the self-association of
aromatic molecules was provided by Martin in 1996 [15], although a few more speciﬁc
follow-up reviews have appeared since that time [14, 17, 21]. To the best of our knowl-
edge, no review speciﬁcally focused on the physico-chemical aspects of the hetero-
association of aromatic molecules has been published, except one paper [22] dedicated
solely to hetero-association of ionic dyes. Even in the simplest two-component hetero-
association system between molecules X and Y, data analysis appears to be complicated
because of the experimental observable needs to be taken into consideration and the
self-associations of both X and Y and their hetero-association X + Y. As a consequence,
some aspects of the hetero-association of aromatic molecules, such as the kinetics of
aggregation and the inﬂuence of metal ions, have not yet been investigated. Charge-
transfer interactions and hydrogen bonding between aromatic molecules, commonly
investigated in non-aqueous solutions or under specially-arranged conditions, are thor-
oughly discussed in the literature (e.g. [11, 23–26]) and outside the scope of this
review. The review will cover all the currently available analyses of hetero-association
in aqueous solutions, starting from probably the ﬁrst studies dedicated to this subject in
the middle of the twentieth century [27–29].
2. Applications of hetero-association
There are at least four mostly well-studied and broadly discussed ﬁelds of the applica-
tions of hetero-association between aromatic molecules:
(1) Physical chemistry applications. The hetero-association of specially selected
(synthesised) aromatic molecules has been used as a model system to provide
insight into various processes of particular importance in chemistry, such as
(a) (b)
Figure 2. (Colour online) (a) Self-association and (b) hetero-association of planar aromatic molecules.
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arrangement of nucleic acid bases derivatives in stacked complexes [23, 30],
binding of drugs to nucleic acids [31] and aromatic residues of proteins
[32, 33], protein–DNA and protein–protein interactions [3, 34], exciton and
charge-transfer interactions [25, 34, 35], dye chemistry [22], electrostatic
complementarity [12, 36], and ‘energetic composition’ of π-stacking [3, 8, 37].
(2) Biochemical applications. The hetero-association in physiological media
between aromatic drugs and other aromatic molecules naturally existing in the
biosystem or intentionally administered (referred to as the ‘guest’ molecule)
leads to a variety of physico-chemical and biochemical effects such as:
(a) chemical degradation of the drug due to speciﬁc chemical interaction with
the guest molecule in the complex. The molecules which exert such effects
are sometimes called ‘the scavengers’ and are extensively reviewed in the
biochemical literature [38–40]
(b) formation of non-covalent hetero-complexes between the drug and the guest
molecule leads to diminution of the fraction of active monomeric species of
the drug in solution able to bind with bioreceptor and exert a biological
effect [39–41]. Such guest molecules, which do not chemically affect the
drug, are called ‘interceptors’ and are currently considered as a means of
directed regulation of a biological effect via changing the structure and the
concentration of the interceptor [42, 43]. The importance of hetero-associa-
tion is manifested in a long-established correlation of the hetero-association
constant, Kh, with an in vitro biological effect for a range of aromatic muta-
gens [19, 44] – a rare example when a physico-chemical parameter of
molecular interaction has a direct link with a biological effect
(c) complexation between a drug and the guest molecule results in alteration of
the bio-kinetics of absorption of the drug in the biosystem and subsequent
changes to its medico-biological effect [42, 45, 46]
(d) the hetero-association of natural aromatic polyphenol molecules with other
naturally occurring aromatic substances (such as chlorogenic acid, caffeine
and gallic acid) is considered to be a mechanism responsible for or to sig-
niﬁcantly inﬂuence various important biochemical processes, such as co-
pigmentation [47, 48] and tea creaming [49]
(5) Pharmaceutical chemistry application (Hydrotropes). Hetero-association is con-
sidered to be the basic mechanism responsible for the widely observed enhance-
ment of the solubility of poorly soluble aromatic drugs in the presence of other
aromatic molecules, commonly referred to as hydrotropes [50, 51]
(6) Medicinal chemistry application. The effect of hetero-association in certain
combinations of aromatic drugs is currently considered to be a potential strategy
for the regulation of the medico-biological activity of aromatic drugs in clinical
practice, e.g. in reduction of the consequences of overdosing of drugs during
chemotherapy [42, 52] or in the production of antimutagenic effects in vivo
[53–55]. The recent in vitro study of cellular effects of a mixture of doxorubi-
cin with fullerene [56], complemented by physico-chemical investigation of
their complexation in physiological media [57, 58], has shown that the effect of
hetero-association may potentially lie behind new applications of fullerene mol-
ecules as elements of combinational chemotherapy of cancer.
A comprehensive review of the well-established ﬁelds of the applications of hetero-
association summarised above is timely. In addition, there are a growing number of
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reports of the successful use of hetero-association of aromatic molecules in the
formation of supramolecular structures having speciﬁc functional roles (e.g. Refs.
[5, 6, 18, 59–61]). It is believed that further understanding of the hetero-association of
aromatic molecules will contribute to the future development of the chemistry of
functionalised supramolecular structures.
3. Theoretical models of hetero-association
3.1. General requirements of a model for hetero-association
The general property of aromatic molecules to form linear aggregates (hydrogen-
bonded or π-stacked) in solution allows one to use essentially similar approaches to
treat the distribution of aggregates as in supramolecular chemistry. The principal
demand of any model of hetero-association is to establish a link between the hetero-
association constant, Kh (or enthalpy, ΔHh, and entropy, ΔSh) and some experimental
observable ξ (e.g. chemical shift in NMR, molecular absorption in spectrophotometry)
[18, 61, 62]
n ¼ uðCH ; cÞ (1)
where CH denotes the concentrations of possible types of complexes H in solution, and
γ is a set of linking parameters, scaling the concentrations CH to the experimentally
detected signals. The concentrations, CH, can be described analytically by applying the
law of mass action, which gives the total concentration of the given type of solute mol-
ecule when summed up over all types of complexes in solution. Hence, the CH values
can be found from solution of the system of mass balance equations. Further ﬁtting of
the experimental titration curve ξexp with Equation (1) by adjusting Kh and γ allows
their values to be determined when the minimum in discrepancy is reached. Many prac-
tical algorithms have been suggested to determine Kh (e.g. [61–64]), and all of them
fall within the general scheme outlined above. It follows from Equation (1) that the
experimental observable and the mass balance equations are the key components of
any model of hetero-association. However, both set of equations depend crucially on
the reaction scheme implied by the investigator regarding the processes of complexa-
tion in solution and both are commonly linked to the immediate conditions of the
experiment. It is this issue that has led to a wide variety of models of molecular het-
ero-association reported in the physico-chemical literature.
The common approach in chemistry when dealing with non-covalent complexation
of two different types of molecules X and Y is, if possible, to reduce the system to sim-
ple m:n complexation, where the m and n are ﬁnite numbers typically limited to 1 and
2. Such reduced models have been widely used to describe various types of hetero-
associations including aromatic molecules, and as they have been thoroughly reviewed
(e.g. [15, 18, 61]) they will not be dealt with here. However, the ability of aromatic
molecules to bind other molecules on both faces of its chromophore, as well as the use
of a wide range of solute concentrations in different experiments, demands that
indeﬁnite aggregation of solute molecules needs to be formally accounted for in both
the homo- and hetero-association complexes, which, as indicated below, creates the
main difﬁculty in building correct models of hetero-association even in the simplest
case of two-component hetero-association. It has been recognised recently that the use
of reduced models of self-association (such as the dimer model) of aromatic molecules
may not be independent of the solute concentration and, more generally, of the
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experimental conditions employed [65]. This should also apply to hetero-association,
suggesting that it is mandatory to take into account indeﬁnite aggregation of molecules
in both the self- and hetero-association models for aromatic molecules. The main body
of current hetero-association studies and those performed during the past decade
appears to take indeﬁnite aggregation into account.
3.2. Analytical approaches to building hetero-association models
The set of currently developed models of hetero-association can be conditionally
divided into three main groups, which differ by the underlying method of mathematical
description of the assembly:
 algebraic approach in the most complete form is presented in Refs. [64, 66]. The
essence of this approach is to write down expressions for the concentrations of
sequentially growing complexes using a sequence-generating function method (or
any other algebraic method, for instance, combinatorial or probabilistic). The sum
of such concentrations in the limit of indeﬁnite association forms a grand parti-
tion function, which enables all the necessary properties of molecular distribution
in solution to be obtained;
 matrix approach in the most complete form is presented in Ref.[67]. The key
object is a stochastic matrix raised to the power of the length of the complexes,
which is equivalent to enumerating all possible types of molecular complexes in
the system, whose contribution to the dynamic equilibrium can be calculated by
the methods of matrix algebra. This approach is essentially similar to the general
transfer matrix formalism. The algebraic and matrix approaches use analytical
evaluations of the main equations of hetero-association model and are commonly
referred to as ‘analytical’ approaches;
 algorithm approach is presented in Refs. [62, 68]. All possible molecular com-
plexes are generated by a special computer algorithm, which computes the concen-
tration and contribution to the experimentally observed parameter from every type
of complex, thereby ruling out the necessity to deal with analytical expressions.
A general treatment of hetero-association, reducing to all major known partial cases
and demonstrating the similarity of the outcome of all these three approaches has been
given [67].
3.3. Evolution of non-cooperative models of hetero-association
Early models of two-component hetero-association, X + Y, used an algebraic approach
to derive the main equations and may be referred to as the ‘1:n’ group of models,
where the X component does not aggregate but there is no restriction to aggregation of
the Y component (n 2 1. . .1) (e.g. [27, 32, 69, 70]). Removal of the restriction to
aggregation of the X compound was ﬁrst pioneered by Magar et al. [71] and later gen-
eralised by Weller et al. [72] resulting in the appearance of ‘m:n’ models. Further gen-
eralisation towards N-component hetero-association was ﬁrst accomplished using either
the matrix approach [73] or the algorithmic approach [62], providing a method to study
any mixture with any possible types of interacting species. However, in early 2000s
[74, 75], it was realised that all the developments cited above, including their partial
cases and the matrix approach [73] contain an overestimation of the so-called
International Reviews in Physical Chemistry 7
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‘reﬂected’ complexes, i.e. physically identical non-symmetric complexes, resulting from
the indeﬁnite summation necessary to obtain the grand partition function in the alge-
braic approach or from matrix multiplications in the matrix approach. An approximate
treatment of the ‘reﬂected’ complexes was ﬁrst accomplished using the algebraic
approach [74–76], but it created another difﬁculty related to the strict treatment of the
experimental observable ξ, referred to as the ‘edge effects’, i.e. the dependence of ξ on
the type of neighbouring molecules in the complex. Complete removal of the problem
of ‘reﬂected’ complexes and ‘edge effects’ was accomplished with respect to a reaction
scheme reduced to no more than two hetero-stacks in all possible hetero-complexes in
solution [75, 76]. Removal of all these limitations was made possible by an
N-component algorithmical model [62, 68, 77] and later by the two-component alge-
braic hetero-association model [66]. A step forward in expanding the algebraic
approach towards N-component hetero-association was attempted with respect to mass
balance equations, although no link to the experimental observable was provided to
account for ‘edge effects’ [78]. Partial removal of this problem was accomplished [79]
resulting in development of the ‘1:m:n’ hetero-association model speciﬁcally adapted to
spectrophotometric data. A complete model of N-component hetero-association has
been developed [67], which accounts for aggregation of all components in solution with
formation of all possible types of complexes, which incorporates the matrix and alge-
braic approaches, which treats strictly the ‘reﬂected’ complexes and ‘edge’ effects, and
which reduces to all major known partial cases.
The models reviewed above are all non-cooperative, i.e. the magnitudes of equilib-
rium self- and hetero-association constants do not depend on the immediate composi-
tion of the interacting aggregates. The model of cooperativity in hetero-association is
very speciﬁc to the system under study. To the best of our knowledge, there are only a
few examples in the literature demonstrating the treatment of hetero-association in
terms of the empirical cooperativity parameter, introduced with respect to formation of
homo- and hetero-aggregates [59, 64, 68, 80].
3.4. Current state-of-the-art and future perspective in the modelling of
hetero-association
Summarising the information on the development of the hetero-association models
given above, it may be concluded that the most strict model of non-cooperative
N-component hetero-association containing all the necessary equations needed to
describe experimental data in solution containing N different types of molecules and
superior to any other hetero-association model is given in [67]. Reduction of this model
to the two-component indeﬁnite ‘m:n’ hetero-association [66] and some other practi-
cally important partial cases, such as ‘1:n’ and ‘1:m:n’ hetero-associations [79] is given
in the cited references. A similar strict treatment of hetero-association can also be
accomplished within the framework of the N-component algorithmical model [62],
though it is limited by the ﬁxed maximum length of complexes, which can be handled
by the algorithm, and requires more computational time. Based on this summary, it is
reasonable to conclude that within the set of common assumptions usually introduced
into the reaction scheme (viz. the independence of the equilibrium constant on the
length of aggregate and additivity of ξ) and fully covered by the models cited above, it
appears that further development of the non-cooperative hetero-association models is
not necessary. However, one issue regarding further development of hetero-association
models is worth noting.
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The success in building the model of hetero-association using the algebraic or
matrix approach is based on the ability to write the mass balance equations and the
equation for ξ in a closed analytical form. The overwhelming majority of known appli-
cations of hetero-association can be successfully modelled by the analytical approaches
(e.g. [32, 42, 61, 64, 67, 73]). Nevertheless, any complication introduced into the reac-
tion scheme may violate analytical derivation of the basic equations, resulting in failure
of the analytical model to describe the system. Immediate solution of the problem will
always be provided by the algorithmical model, which does not deal with equations at
all and is able to treat a reaction scheme of any complexity. We suggest that a similar
problem may arise in the future with respect to application of some experimental meth-
ods in hetero-association studies, which do not follow the nearest-neighbour principle
in writing ξ for each particular hetero-complex, CH, in Equation (1) (such as those mea-
suring diffusion of molecules), thus presumably making great difﬁculty in obtaining ξ
in an analytical form. Another complication might occur if the condition is broken of
equal K for self-association and equal Kh for hetero-association and the introduction of
the recently developed proﬁle of equilibrium constant [81, 82] and/or the introduction
of the cooperativity parameter into the main equations, which is currently considered to
be of special importance in supramolecular chemistry [59, 64].
Also, we need to highlight the recent appearance of a novel challenge to further
development of the hetero-association models towards description of two- and three-
dimensional aggregation of aromatic molecules due to mixed type of interactions
involving face-to-face and edge-to-edge bindings [20]. Hence, the story of the develop-
ment of hetero-association models needs to continue.
4. Structure and thermodynamics of hetero-association
Systematic investigations of hetero-association have been performed for a number of
different aromatic systems. A list of hetero-association parameters for these aromatic
systems is given in Table 1, providing, where appropriate, information on the equilib-
rium constant of hetero-association (Kh), associated thermodynamic quantities (ΔHh and
ΔSh), the change in solvent-accessible surface area (ΔSASA), the change in the area of
overlap of the chromophores of interacting molecules in the hetero-complexes (ΔAh)
and the experimental method used.
Investigations of hetero-association have been mainly performed for the following
sets of aromatic molecules.
4.1. Hetero-association of derivatives of nucleic acid bases
The hetero-association of derivatives of nucleic acid bases historically represents the ﬁrst
example of systematic investigation of the hetero-association phenomenon for aromatic
molecules. The aim of these investigations, as in the case of self-association, was to gain
deeper understanding of the stacking interactions in stabilising nucleic acids. Quantitative
parameters of the hetero-association in solution of various combinations of derivatives of
nucleic acid bases have been reported for purine–purine, purine–pyrimidine and pyrimi-
dine–pyrimidine interactions [27, 70, 71, 83–89]. Derivatives of nucleic acid bases tend
to form stacking-type complexes in aqueous solutions with minor contribution, if any,
from in-plane hydrogen-bonding (base-pairing), as deduced from the monotonic shift of
aromatic protons to lower frequency in NMR [70, 83, 85, 86, 88, 89] or the hypochromic
effect in UV–vis spectroscopy [90–92] on increasing concentration or decreasing
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temperature, and also supported by high-level quantum-chemical computations [93–96].
Lowering the pH of the medium leads to protonation of purine and pyrimidine rings,
which is considered to result in weakening of their stacking ability with other molecules
[70, 97]. The stacking-type of hetero-association does not disappear even in organic
solvents at very low (pH ~1) or very high (pH ~13) pH [89].
In general, the derived magnitudes of the equilibrium hetero-association constants
(Kh) have values in between the self-association constants of the interacting compounds
[23, 27, 70, 85–87, 98, 99], except for a very few reports [27, 84, 100] which,
however, were not linked to the physico-chemical properties of the interacting
molecules. It was found that Kh for the interaction of purine derivatives is, on average,
higher than that for purine–pyrimidine which, in turn, is much greater than for
pyrimidine–pyrimidine interactions [23, 84, 87, 98]. Based on these results, it was con-
cluded that hetero-association of derivatives of nucleic acid bases in water is largely
governed by van der Waals interactions between the molecules in hetero-complexes,
which are known to correlate with the dimensions of aromatic portion of the interacting
molecules [11, 86, 87]. This conclusion is supported by the fact that on average the
magnitude of thermodynamical parameters increases with the number of overlapping
aromatic rings in the hetero-complex, viz. 2:2 > 2:1 > 1:1 (Figure 3). The magnitude of
interaction increases with addition of divalent cations [88] in a qualitatively similar
way to that known for self-association [17], although the inﬂuence of added metal ions
has never been studied systematically with respect to the hetero-association of nucleo-
tides and nucleosides and their derivatives.
The tendency to hetero-association was found to depend strongly on the type of
substituents; for example, Kh increases with methylation of purine and pyrimidine
bases, which was interpreted in terms of either greater hydrophobic or van der Waals
contribution to the thermodynamics of complexation [70, 83–86, 98]. However, methyl-
ation also leads to alterations in the structures of 1:1 hetero-complexes due to the steric
demands to accommodate the methyl group within the complex (an increase in distance
and induction of partial overlap between the chromophores) [85, 101]. As a result
of these observations, it was suggested that electrostatics plays an important role in
0
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2500 K h , l/mol
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20
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35
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1:1 2:1 3:1 4:1 2:2 3:2 4:2 3:3 4:3 1:1 2:1 3:1 4:1 2:2 3:2 4:2 3:3 4:3
|ΔHh |, 
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(b)(a)
Figure 3. Dependence of mean Kh (a) and ΔHh (b) on the number of fused aromatic rings m:n
in the structure of X(m) and Y(n) molecules forming hetero-complexes. Mean values were calcu-
lated by averaging over data-set collected from Refs. 1:1 [85, 87, 97], 2:1 [70, 84, 87, 97, 99,
100, 188, 225], 3:1 [154, 182, 197], 4:1 [33, 189, 197], 2:2 [69, 84, 135, 147, 166], 3:2 [42, 53,
54, 108, 125, 127, 128, 132–135, 137, 143, 145, 150, 154, 159, 161, 188], 4:2 [33, 42, 127,
134, 135, 138, 149, 168], 3:3 [75, 184–186, 190, 214], 4:3 [74, 189, 210, 211, 213–215] under
conditions [pH ~7, T = 25… 30 °C, aqueous solution]. For the source data see also Table 1.
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determining the structural features of the hetero-complexes [85, 89] and was later
suggested as a general feature of ‘electrostatic complementarity’ in aromatic stacking
[12, 102]. Similarly, ‘structural complementarity’ was also suggested as being important
for the hetero-association of various tautomeric and isomeric forms of nitrogen bases in
solution [70]. The same effect as discussed above for the methyl group is also produced
by attaching other alkyl groups to the chromophore of the molecule [84, 103], which
was interpreted in terms of the assumption that the carbon-bonded alkyl groups enhance
the polarisability of the heteroaromatic system and consequently base-stacking through
dipole-induced dipole interaction.
Halogen substituents exhibit a marked enhancing effect on hetero-association, as
demonstrated for the interaction of 5-halogenated uracils with adenine [84]. The
enhancing effect was found to be of the same order as that for increasing the van der
Waals radii for the substituents, as well as the increasing polarisability of the molecule,
indicating the importance of the contribution of electronic effects and London disper-
sion forces in stabilising complexes in aqueous media. The addition of a sugar moiety
to the structure of pyrimidine or purine commonly reduces the hetero-association con-
stant due to steric hindrance; the existence of a 2′-OH group in the sugar reduces Kh
even further [84]. Although stacking interactions in aqueous media are generally con-
sidered to be non-speciﬁc, the strong dependence of the tendency for hetero-association
in a homologous series of compounds on the type of side chains indicates that some
structural features may discriminate between the interactions of some pairs of com-
pounds from other pairs [84].
It should be noted that the structures and types of side chains seem to affect the
magnitude of Kh to a greater extent than changes in the type or position of hetero-
atoms in purine or pyrimidine chromophores. Studies on hetero-association involving
pyrazole analogues of nucleic acids [70], 2-ring quinoxaline [84], chloroquine [84]
and indole [32] derivatives, some aromatic aminoacids [32], and 1-ring sodium
benzoate and salicylate [104] reported magnitudes of binding constants similar to or
within the same region of discrepancy as for the corresponding purines or
pyrimidines.
There are only few reports available in literature on the measurements of enthalpy
(ΔHh) and entropy (ΔSh) of hetero-association of nucleotides and nucleosides and their
derivatives (e.g. [70, 100]), and so general conclusions on the interrelation between
these quantities and the physico-chemical properties of the interacting molecules cannot
be made. The magnitudes of ΔHh and ΔSh fall in the same region of values as previ-
ously measured for self-association [23, 27, 100], and are of negative sign, suggesting
the importance of van der Waals (of which dispersive forces are considered as the most
important) and, possibly, charge-transfer interaction in the thermodynamics of hetero-
association. In this respect, it is worth noting that there is no apparent indication of the
importance of charge-transfer in hetero-complexes of nucleic acid bases derivatives in
neutral aqueous solution, except for a few reports based on analysis of UV–vis spectra
(e.g. [101]).
In general, studies of the hetero-association of derivatives of nucleic acid bases do
not lead to any new principals about molecular interactions and the results are in line
with information deduced from much more extensive and detailed self-association stud-
ies of these molecules [17, 23]. The hetero-association of derivatives of nucleic acid
bases is mainly a matter of historical interest.
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4.2. Hetero-association of aromatic drugs with derivatives of nucleic acid bases
The initial aim of investigations into the complexation of derivatives of nucleic acid
bases with aromatic drug molecules was to search for a pattern in molecular interac-
tions, in order to utilise this information in studies of aromatic ligand binding with
nucleic acids. A more speciﬁc goal was linked to the complexation of various drugs to
ATP whose intracellular concentrations in vivo may reach very high values ~100 mM
[105].
The antibiotic actinomycin D [106–109] and the dye ethidium bromide [110] were
the ﬁrst DNA-complexing agents investigated systematically in their binding with
nucleosides and nucleotides. It was found that hetero-association of these molecules
may be characterised by the stacking type of association, which had led to the sugges-
tion of an intercalation type of binding of these compounds with DNA. Conclusions
about the predominant location of the chromophore of the base above the chromophore
of the ligand were made from the calculated values of the induced proton and carbon
NMR chemical shifts of the bases. In some cases, the approximate orientation of the
base with respect to the antibiotic in 1:1 complex was estimated on the basis of com-
parison between experimental and theoretically calculated proton magnetic shielding
[69, 111]. In the majority of cases, stacking between the ligand and mononucleotides
obtained in aqueous solution is in line with crystallographic studies [106]. It is impor-
tant to note that a typical distance, d = 0.34 nm, between the chromophores of the drug
and mononucleotide in the 1:1 complex comes from X-ray diffraction analysis [112].
Similar results were later obtained for the antibiotics daunomycin [113] and doxorubi-
cin [33], xanthines [111, 114–116], psychotomimetic drugs [69], quinolones [117],
polyphenols [118], and other aromatic drugs. It was shown that hetero-association is
enhanced by the presence of divalent metal ions due to interaction of the drug with
nucleoside phosphates via the ion, as demonstrated for the ﬂuoroquinolone antibiotics
[117]. However, the exact mechanism of stabilisation depends on the structure of inter-
acting molecules and does not always require the presence of the phosphate group
[119].
The thermodynamical pattern of the binding of drugs with nucleosides and nucleo-
tides appears to be qualitatively the same as previously found for the hetero-association
of derivatives of nucleic acid bases, viz. the magnitudes of the hetero-association
parameters are intermediate between the corresponding self-association parameters of
the interacting molecules and the values of ΔHh and ΔSh [33, 111] are both negative. It
was realised, however, that the average magnitudes of Kh and ΔHh are higher in abso-
lute value than those for the hetero-association of the derivatives of nucleic acid bases,
which was suggested to be due to a more extended aromatic system of the drug (typi-
cally 2–4 aromatic rings in the chromophore) [33, 69]. The key role of hydrophobic
and van der Waals interactions in stabilisation of hetero-complexes was postulated [33,
108]. In particular, the importance of hydrophobic interactions was recognised due to
increasingly negative entropy of hetero-association in the presence of increasing metha-
nol concentration [108], and the correlation between the Kh and the size of the ring sys-
tems of the interacting molecules [69]. However, the electrostatic factor is important in
determining the value of Kh [33, 69, 118], unlike the hetero-association of derivatives
of nucleic acid bases. A typical example is the incremental enhancement of Kh for
binding of the positively charged doxorubicin to the negatively charged adenosine-
phosphates in the series AMP < ADP < ATP [33] and the relatively strong binding of
the ﬂavylium cation with ATP [118]. The electrostatic factor was also suggested as
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important in differentiating the binding of ATP with caffeine, theophylline and theobro-
mine [115], which was correlated by the authors with the π-electron deﬁciency of the
xanthine molecule.
Although characterised relatively well in the past, the use of nucleosides and nucle-
otides as a model systems to complex with aromatic drug molecules is still extensively
used to get insight into various processes of biochemical importance.
4.3. Hetero-association of aromatic drugs with aromatic interceptor molecules and
hydrotropes
Early investigations of hetero-association mainly provided supporting information to
investigations of the complexation of aromatic antibiotics with DNA, and typically did
not have their own scientiﬁc importance. However, the ﬁrst reports about a decrease/
increase in the toxicity of antitumor aromatic drugs in the presence of caffeine (for
reviews see [19, 43]) appeared at the end of the 1970s and early 1980s, which stimu-
lated investigations into the mechanism of the action of caffeine and other methylxan-
thines. The hetero-association with xanthines (termed the ‘interceptor’ action) had been
ﬁrst suggested as the principal factor altering the biological activity of the drugs [52,
120, 121] and carcinogens [122, 123], which was supported later on by numerous
in vitro studies [121, 124–128]. The search for other aromatic interceptor molecules
resulted in discovering the interceptor effect of chlorophylline (CHL) [41, 44] and ribo-
ﬂavin [vitamin B2 (RBF) or its analogue, ﬂavin-mononucleotide (FMN)] [129–131].
Subsequent physico-chemical investigations of the hetero-association of aromatic mole-
cules with potential interceptors, already existing or newly synthesised, conﬁrmed that
hetero-association is the primary mechanism responsible for the observed biological
effects [19, 43].
In addition to the interceptor effect, hetero-association has long been known as the
molecular mechanism for enhancing the solubility of various aromatic drugs thereby
making hetero-association important in pharmaceutical chemistry. In particular, analysis
of quantitative thermodynamic information on hetero-association has established a cor-
relation between Kh (or other binding parameters) and changes in the in vitro biological
effect for various aromatic mutagens and antibiotics [44, 132], and with solubility
enhancement for various aromatic hydrotropes [50, 51].
In summary, the data accumulated on the hetero-association of drugs with intercep-
tor molecules constitute the largest portion of the total published volume of information
on hetero-association, which is discussed in more detail.
4.3.1. Drug-xanthine system
Hetero-association in Drug-xanthine systems has been extensively studied by NMR,
UV–vis, Fluorescence spectroscopies, titration microcalorimetry, partitioning in water–
organic mixture, molecular modelling and other techniques for the following aromatic
drugs: daunomycin (DAU) [127, 133–136], doxorubicin (DOX) [33, 42, 127,
137–139], actinomycin D (AMD) and its derivatives [133, 140–143], benzene and its
derivatives [122, 144], novantrone/mitoxantrone (NOV) [42, 127, 135–137, 145, 146],
nogalamycin (NOG) [138], norﬂoxacin (NOR) [135, 136, 147], camptothecins [139, 148,
149], quinoxaline [84], chloroquine [84], DAPI [150], phenothiazines [121, 151, 152],
riboﬂavin [135, 153–155], porphyrins [156, 157], acridine mutagens [53, 54, 124,
125, 133–136, 158–160], phenanthridine mutagens [133–137, 150, 160–162],
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imidazoquinoline-type (IQ) aromatic amines [128], aromatic neurotoxins [126], poorly
soluble pharmaceutical drugs [163] and polyphenols [118, 164–166]. It was generally
found that the magnitudes of equilibrium hetero-association constants obtained by differ-
ent methods correlate well with each other and lie in between the self-association con-
stants of the ligand and xanthine [19, 53, 68, 114, 124, 133–135, 138, 158]; a few
exceptions (e.g. [166]) were interpreted in terms of speciﬁc intermolecular interactions
involving water molecules with the 1:1 hetero-complex. A similar situation was also
observed for the thermodynamical parameters (enthalpy and entropy) suggesting the
absence of any additional stabilisation of the hetero-complexes in solution [68]. The high-
est magnitudes of Kh were found for the hetero-association of CAF with the antibiotic
NOV (Kh = 324 M
−1 [145]), TPT (Kh = 320M
−1 [149]), antimalarial agent halofantrine
(HAL) (Kh = 637M
−1 [163]) and porphyrins (Kh > 1000M
−1 [156, 157]), and for the
mutagen AO with tetramethyluric acid [132] at room temperature and pH ~7. However,
the correlation of Kh with the self-association constants of interacting compounds, X and
Y (i.e. KX, KY), did not enable the absolute value of Kh to be used in a comparative analy-
sis of various systems by their hetero-association ability. A quantitative measure fh was
developed in Equation (2) to estimate the relative contribution of hetero-association to the
dynamic equilibrium in solution, determined as the relation of the equilibrium constants
of self-association of the interacting compounds, X and Y (KX, KY), and the constant of
their hetero-association (Kh), [68]:
fh ¼ KhKX þ KY þ Kh (2)
The highest value of fh was noted for the CAF-FMN system, which was interpreted as
a consequence of additional stabilisation of the 1:1 hetero-complex by intermolecular
hydrogen bond, supported by structural modelling [153, 167].
It was concluded that complexation of aromatic ligands with xanthines results from
π–π stacking at pH close to neutral, which is based on systematic NMR magnetic
shielding of aromatic protons of xanthine (or a drug) on increasing the concentration of
the drug (or a xanthine) [115, 122, 133–135, 138, 145, 147, 149, 163], on speciﬁc
changes in absorption of the drug in the visible range of the spectrum (hypochromic
and bathochromic shifts) on increasing the concentration of xanthine [42, 53, 54, 124,
128, 137, 150–152, 157, 159] and on red-shifts in the absorption/emission bands in
ﬂuorescence [53, 137, 140, 157]. The overwhelming majority of published NMR work
on hetero-association reports that π-stacking affects the value of chemical shift, except
in a few very rare examples, e.g. halofantrine-caffeine hetero-association [163], report-
ing concomitant change in splitting pattern of the signal of the observed nuclei, which
may be treated as an exception. Stacking appears to be preserved on lowering the pH,
although Kh generally becomes smaller as a consequence of protonation of the interact-
ing molecules [115, 128] (or, much more rarely, becomes higher [163]) or increasing
pH [115]. However, at acidic pH the co-existence of stacking and in-plane hydrogen-
bonded complexes may be the case, as demonstrated for CAF hetero-association with
some polyphenols [118]. The binding of CAF with a range of polyphenolic molecules
was generally characterised by stacking-type hetero-association with contributions from
intermolecular H-bonding in some cases [164–166]. The majority of published work on
hetero-association in drug-xanthine systems in aqueous solution report that the major
contribution to their stabilisation is given by hydrophobic and van der Waals dispersive
interactions of aromatic chromophores in the π-stacked hetero-complexes. In rare cases
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(viz. CAF hetero-association with FMN/RBF [155], actinomycins [141, 142] and
porphyrin [157] derivatives) based on the results of molecular modelling, an intermo-
lecular hydrogen bonding between the molecules in 1:1 hetero-complexes was sug-
gested as a source of additional stabilisation. The importance of charge-transfer
interactions has also been proposed for drug-xanthine systems [54], although no solid
experimental evidence has so far been obtained for such hetero-associations in aqueous
solutions. Moreover, measurements of proton spin–spin relaxation times in the hetero-
complex of CAF with 6-oxybenzo[a]pyrene [122], and the absence of an apparent
charge-transfer band in the absorption spectrum [128, 140] suggested that charge-trans-
fer, if any, is not a driving force for the hetero-association reaction. On the other hand,
complexation of CAF with aromatic donors in CDCl3 provided evidence that electro-
static interactions and charge transfer may provide the dominant contribution to stability
of the complexes [144].
For all the ligands studied, there is general agreement on the most probable spatial
structures of the 1:1 hetero-complexes in solution built by molecular modelling meth-
ods. The resultant structures are supported, if available, by NMR spectroscopy data,
viz. indirect (magnetic shielding, e.g. [133–135, 138, 143, 145, 147, 149, 153, 164])
and direct (in very rare cases intermolecular proton–proton nOes, e.g. [164, 166]) struc-
tural information. The chromophores of the drug and xanthine in the majority of cases
are oriented in a way to maximise the area of their overlap (i.e. the longitudinal axes
of the chromophores of the drug and xanthine molecules tend to be parallel) [42, 124,
125, 133, 135, 137, 139, 159], except for the cases of THP-NOV [135] and, probably,
CAF-DOX [139] systems in which the longitudinal axes are nearly orthogonal (the
CAF-DOX seems to be the only system for which the early [42, 137] and recent [139]
calculations of the structure of 1:1 hetero-complex disagree with respect to the angle of
orientation of CAF to the DOX chromophore). The key difﬁculty in structural model-
ling of drug-xanthine systems is that the xanthine molecule allows at least two possible
orientations differing by 180º in the complex with the drug [133, 137, 139], which
sometimes cannot be reliably discriminated by experiment or in structural modelling. In
the majority of cases, a typical aromatic stacking distance of 0.33–0.35 nm between the
chromophores of the molecules in 1:1 complexes was reported. Due to the large differ-
ence in dimensions of xanthine molecules and some drugs (such as the 4-ring DAU,
DOX,NOG,TPT molecules), a small deshielding (or nearly zero shielding) of certain
peripheral aromatic protons was observed in complexes with CAF and methylxanthines
[135, 138], which was interpreted as being due to these protons falling out of the
shielding cone of the xanthine chromophore. A similar effect was also observed for the
hetero-association of the 2-ring antibiotic NOR with the 4-ring anthracyclines [168].
No apparent evidence was reported for the formation of in-plane complexes due to
hydrogen bonding, or simultaneous accommodation of two xanthines on the chromo-
phore of the drug, or other types of arrangements of aromatic chromophores in hetero-
complexes (such as perpendicular, suggested to occur in CDCl3 [122]).
It is worth noting that, in the majority of cited papers on the hetero-association of
aromatic molecules, aggregations higher than dimer in either 1:1 homo- and/or hetero-
complexes are assumed and used in derivation of the model of hetero-association
(except for particular cases of very small concentrations of interacting molecules, where
the contribution from high-order aggregation may be ignored). The possibility of forma-
tion of higher order hetero-complexes, such as 1:2 complexes, for planar aromatic mol-
ecules, has long been known (e.g. [169]) and with respect to drug-xanthine systems,
indirect evidence has been given from measurements of rotational correlation times by
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NMR and comparison of optical absorption and ﬂuorescence spectra of aromatic mole-
cules in DNA intercalated state and in hetero-complexes [122], as well as from recent
molecular dynamics simulations in water [155]. Based on ﬂuorimetric titrations, it was
also suggested that the aromatic antibiotic AMD can bind into caffeine clusters com-
prising 8–12 molecules, which may serve as a carrier of the antibiotic to DNA [140].
A qualitatively similar effect was reported [170], where CAF was shown to intercalate
into clusters formed by some polyphenolic molecules present in tea, which stimulates
tea cream formation.
A correlation between the hetero-association parameters and types of side chains
was reported, such that the existence of large side chains in the molecular structures of
AMD, AO, NOV results in a pronounced positive hydrophobic contribution to the
entropy of hetero-association and subsequent increase in Kh [54, 133, 145]. The most
drastic effect on Kh is seen on increasing the number of methyl groups in the structure
of xanthines from mono-methylxanthine to di-, tri- and tetra-methylxanthine [54, 115].
Addition of oxygen or chlorine at C8 also increases the binding afﬁnity [54]. A more
subtle and not yet completely understood effect on Kh is the variation of the position of
methyl groups in the xanthine structure. In mono-methylxanthines the existence of
methyl groups at the 1 or 3 position signiﬁcantly enhances hetero-association, whereas
position 7 appears to be unimportant, and in dimethylxanthines [i.e. theophylline
(THP), paraxanthine, pentoxifylline (PTX) and theobromine (THB)] variation in the
1,3,7 position of the two methyl groups, as well as addition of a –(CH2)n–COOH group
as a potential hydrogen bond donor/acceptor, did not result in apparent change in the
magnitude of Kh [54, 125, 128, 134].
There is some disagreement in the literature about the inﬂuence on Kh of addition
of a third methyl group (i.e. CAF) to the structure of dimethylxanthine. Based on spec-
trophotometric titration of AO, it was found that Kh for CAF is higher than that for
dimethylxanthines and explained by a pronounced hydrophobic contribution [54, 132].
(At this point, it is worth noting that the Kh values in AO-THP/THB (e.g. see [53,
132]) and DAU-CAF/THP (e.g. see [127]) systems are not in complete agreement
between different authors and different methods, which makes their comparative analy-
sis less informative). A qualitatively similar result was obtained from NMR titration of
ATP with CAF, THP and THB [115], but explained by the authors by electrostatic fac-
tor (i.e. degree of π-electron deﬁciency of the xanthine derivatives). Other investigators
reported that CAF binding with DAU/DOX/NOV [127] or acridine mutagens [125]
may be characterised either by higher or lower Kh as compared with THP (or PTX),
although no interpretation was given. And, ﬁnally, NMR-based titration of various
drugs (viz. EB, PF, DAU [134] and IQ-type amines [128]) by CAF and dimethylxanth-
ines has led to a contrasting conclusion that removing the third methyl group leads to a
slight increase in hetero-association ability. The exceptions are (i) the THP-NOV sys-
tem [127] in which the orthogonal orientation of the chromophores in the 1:1
hetero-complex resulted in minimisation of the overlap area and consequently lower
magnitude of Kh as compared with CAF, and (ii) the THP-AO system, featuring lower
Kh with respect to CAF-AO due to a decrease in the efﬁcacy of hydrophobic interac-
tions of methyl groups in the 1:1 complex [53, 54, 132]. These results reﬂect very
complex patterns of the interplay between the type of side chains and the magnitude of
Kh in hetero-association ability, as previously known from self-association studies of
tri- and di-methylxanthines [134] and explained by steric hindrance created by three
methyl groups in the structure of CAF.
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The importance of steric hindrance in hetero-association is also supported by the
facts that the binding of dimethylxanthines by proﬂavin, which does not contain
methyl/ethyl groups, was characterised by the highest magnitude of Kh [134]. A quali-
tatively similar effect was reported for binding of phenanthridine dyes with CAF [133],
viz. an elongation of the alkylamine side chain in EB (transforming EB into PI, see
Figure 1) resulted in lower Kh. On the other hand, the predominantly hydrophobic het-
ero-association of AO with tetramethyluric acid, containing 4 methyl groups, is charac-
terised by relatively high hetero-association constant, Kh = 552M
−1 [132]. Similar
predominant effects of hydrophobic interactions were noted when replacing 3,8 imino
groups in PF by dimethyl groups in AO (see Figure 1), which gave a marked increase
in Kh [133]. An even more complex interplay of the effect of side chains and the struc-
ture of chromophore was reported for the case of CAF binding to porphyrins, which
additionally involve the coordination of the CAF molecule by zinc in the centre of the
porphyrin molecule [156].
These results highlight the key role of ‘structural complementarity’ in hetero-associ-
ation and its competition with hydrophobic tendency of stacking in aqueous solution,
which is generally in line with what is known to date from hetero-association of the
derivatives of nucleic acid bases (see Section 4.1) and, in fact, determine the speciﬁcity
in structures of 1:1 hetero-complexes. A typical demonstration of the competition of
these two factors is the absence of any apparent pattern in the magnitude of Kh for the
binding of CAF and THP with AO/DAU/DOX/EB/PF/NOV discussed above, and for
the binding of CAF, THP and pentoxifylline to IQ-type amines, which differ in the
number of nitrogens in the aromatic chromophore (determining the aromaticity of the
molecule and strength of van der Waals interactions) and the number of CH3 groups
(determining the strength of hydrophobic interactions) [128]. On the other hand, the
enthalpy of hetero-association, manifesting the contribution of the van der Waals factor,
gives the highest values for IQ-type amines with the smallest number of nitrogens in
the chromophore, as expected [128].
Thermodynamic parameters (ΔHh, ΔSh) have been determined nearly for all the
drug-xanthine systems cited above, using the temperature dependence of experimental
observable (commonly, chemical shift in NMR or molar absorption in UV-Vis) and
van’t Hoff analysis. The known calorimetrically determined enthalpy of hetero-associa-
tion of CAF with TPT [148], DAPI [150], NOV [42], MPTP [126], IQ [128], porphy-
rin [156] and HAL [163] systems falls within the typical range of van’t Hoff derived
enthalpies [115]. The magnitudes of ΔHh and ΔSh are large negative values, indicating
the importance of van der Waals interactions in the net energetics of the hetero-associa-
tion reactions. The sole exception is the CAF-NOV system, characterised by a small
positive ΔSh, which was explained by a pronounced hydrophobic contribution [145].
The typical range in variation of enthalpy is from −15 to −47 kJ/mol [42, 128], and a
clear dependence of ΔHh on the number of fused rings in chromophore and their aro-
maticity was reported [128] (see also Figure 3). It should be noted that this correlation
is also typical for Kh and was clearly demonstrated for CAF binding with a range of
polyphenolic molecules differing in the number of fused rings in the chromophore
[170]. Systems falling outside of the typical range of enthalpies are those close to zero
value, i.e. ΔHh = −624 J/mol for CAF-MPTP [126], presumably due to minimal overlap
of aromatic moieties in the hetero-complex, and for the CAF-quinacrine mustard system
with ΔHh = −486 J/mol [124], which is difﬁcult to interpret so far.
The range of variation in entropy is approximately −20 to −50 J/mol K and in the
majority of cases was related to the presence of hydrophobic groups in the structure of
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the drug and xanthine molecules. Interestingly, at neutral pH, no apparent correlation
was reported between the existence of charge on the drug molecule with either Kh or
ΔHh, ΔSh, and the dependence of Kh on counterion concentration seems to be not sig-
niﬁcant [158, 159], indicating only small contributions from ion-dipole interactions.
This is not correct, however, if the electrostatic component is assumed to be dominant
as demonstrated for ATP binding with xanthine derivatives at different pH [115]. More-
over, the magnitude of Kh may either increase or decrease on increasing the ionic
strength, which is strongly dependent on the electronic properties of the interacting
molecules [115, 158]. Unfortunately, data on the inﬂuence of di- or multi-valent metal
ions on hetero-association are scarce and do not enable any general conclusions to be
made. In the study of CAF complexation with a range of polyphenolic molecules
[170], it was shown that glucose and calcium have little effect on hetero-association.
However, the existence of zinc in the structure of porphyrin molecule, in part, is
responsible for the highest known magnitudes of the hetero-association constants (Kh >
1000M−1 [156, 157]) and relatively high enthalpies (ΔHh = −30…−40 kJ/mol [156])
with xanthine derivatives.
4.3.2. Drug-vitamin system
There are some early investigations of the hetero-association of the riboﬂavin vitamins
(RBF or FMN) with other aromatic compounds: the complexation of RBF/FMN with a
series of betacarbolines, indoles [171–175], simple hydrocarbons [176–180] and some
antibiotics [129, 130]. The formation of 1:1 stacked complexes of aromatic molecules
was reported, where an increase in stability and lowering of entropy was related to the
increase in aromaticity of the drug chromophore in RBF-drug complexes for a series of
betacarbolines and some other hydrocarbons [171]. Similar conclusions regarding the type
of complexation were also made in studies of the hetero-association of RBF with nicotin-
amide [181, 182] and with sodium salicylate [154, 183]. Speciﬁc changes in spectral
parameters (absorption and ﬂuorescence) were interpreted primarily with respect to substi-
tuent functions in the aromatic rings. In the majority of cases, early investigations of RBF
hetero-association with other aromatic molecules resulted in the view that charge-transfer
interactions are likely to be the most important factors stabilising the hetero-complexes.
When antidepressants, which also include a group of betacarbolines (BC), are used
in the treatment of depression and Parkinson’s disease, some suppression is observed of
the enzyme activity of monoaminooxidase (MAO) – a ﬂavoenzyme which catalyses the
oxidative deamination of certain important biogenic amines [171]. In order to under-
stand the molecular mechanism of this effect, an investigation was conducted of the
interaction of a series of structurally selected BCs and indoles with two typical repre-
sentatives of the ﬂavin family (FN), riboﬂavin and ﬂavin-mononucleotide, [171–175].
The formation of 1:1 non-ﬂuorescent molecular complexes was observed and the equi-
librium constants and thermodynamical parameters of complexation were calculated.
For the series of BC derivatives, it was found that FMN forms more stable hetero-com-
plexes than RBF. The authors tried to correlate the FN-BC complexation with the
suppression of MAO, and came to the conclusion that the change in MAO activity was
related to the sequence of FN-BC complexation constants that depended on the aroma-
ticity of the BC chromophore.
The most detailed investigations of the hetero-association of RBF/FMN-drug systems
were recently carried out by NMR spectroscopy under similar solution conditions
(0.1 M ionic strength, pH ~7). The structural and thermodynamic parameters of
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hetero-association were determined from analysis of the concentration and temperature
dependences of chemical shifts of the non-exchangeable protons of both aromatic
compounds in mixed solutions of FMN with the antibiotics, DAU, NOG, AMD, NOV
[184–187], NOR [188] and TPT [189], and the mutagens, EB and PF [190]. It was con-
cluded that sandwich-type complexes of aromatic molecules were formed in solution,
which were stabilised by stacking-interactions of the chromophores. The FMN-NOV sys-
tem studied by NMR [185] provided a rare case of the co-existence of homo- and hetero-
complexes of the interacting molecules in solution, manifested by a change of a shape of
the titration curve compared to the typical concave form into the extremum-containing
shape originating from the competition of magnetic shielding in various complexes.
The structures of 1:1 hetero-complexes conform to the general tendency to maxi-
mise the overlap area of the chromophores of the interacting molecules. The magni-
tudes of equilibrium hetero-association constants for FMN interaction with NOG,
DAU, NOR and AMD were intermediate in value between the equilibrium constants of
the self-association of the individual molecules, whereas the magnitudes of the hetero-
association constant for FMN interaction with NOV, EB and PF were greater than the
corresponding self-association constants, which indicated that hetero-association of
these aromatic compounds was energetically more favourable [185, 190]. Quantitative
analysis of the thermodynamic parameters of the interaction of FMN with these mole-
cules, complemented by direct structural information derived from two-dimensional
NMR spectra, resulted in the conclusion that intermolecular hydrogen bonds were
responsible for the additional stabilisation of the hetero-complexes (Figure 4). These
Figure 4. (Colour online) Example of 1H-1H 2D-ROESY NMR spectrum of the FMN-PF
mixture in aqueous solution (redrawn from [190]). The inset contains the calculated spatial struc-
ture of the 1:1 hetero-complex. Solid lines indicate intermolecular nOe cross-peaks and the
dashed line indicates the proposed H-bond.
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results were later supported by quantum-chemical calculations [167], statistical analysis
of large data-set of hetero-complexes [191] and studies using vibrational spectroscopy
[192]. The existence of an intermolecular H-bonding in the RBF-NOR complex was
also implied [193] based on high negative values of thermodynamic parameters. Inter-
estingly, the magnitude of the hetero-association constant derived from ﬂuorimetric
titration resulted in Kh having magnitudes of the order of 10
5M−1 which is 2–3 orders
of magnitude higher than typical values of Kh derived from NMR or UV–vis studies,
whereas the enthalpy change appears to be consistent within the three methods. The
distance between the chromophores from ﬂuorimetry [193] is also inconsistent with
NMR data and molecular modelling [188] and so these results could be treated as an
exception, because in more systematic studies of drug-xanthine systems (reviewed
above) the quantitative parameters of hetero-association obtained by various methods
are in general agreement.
Another type of aromatic vitamin, nicotinamide (NMD) and its derivatives, which
possesses effective solubilising properties with respect to aromatic drugs, has been thor-
oughly investigated [119, 154, 163, 181–183, 189, 194–197]. Using various experimen-
tal techniques, it was conﬁrmed that the general mechanism of the solubility
enhancement of the drugs in the presence of NMD originates from the formation of 1:1
hetero-complexes. These studies concluded that π-stacking interactions played the pre-
dominant role in formation of the complexes, and provided the same qualitative infor-
mation on the thermodynamics of hetero-association as previously known from
interactions of drugs with derivatives of nucleic acids (see Section 4.2). In particular,
the hetero-association of NMD with various drugs is always characterised by lower
magnitudes of Kh and other thermodynamic parameters compared to RBF/FMN or
CAF, which is correlated with a lower solubilising potency of NMD than RBF under
similar conditions. The binding of NMD to the antibiotic DOX was signiﬁcantly
enhanced in the presence of Fe(III) ions [119], representing a very rare case where the
inﬂuence of metal ions on hetero-association was directly investigated.
One speciﬁc issue regarding the NMD-drug and FMN-drug hetero-association is
worthy of special consideration. It was assumed that two 1-ring nicotinamide molecules
could potentially be simultaneously accommodated on one face of the 3- or 4-ring
chromophores of some of aromatic drugs (e.g. [163]). Microcalorimetric studies have
pointed to the formation of 2:1 NMD-HAL complexes, although no distinction was
provided on whether this results from 2:1 or 1:1:1 complexes of two nicotinamides
with one halofantrine drug [163]. The NMR investigation of NMD-DAU/NOV hetero-
association speciﬁcally designed to distinguish between 2:1 and 1:1:1 types of binding
indicated that the latter is more probable [197]. The binding of the 3-ring FMN mole-
cule with the 4-ring topotecan drug indicated some preference for 2:1 type of binding,
although no ﬁrm evidence for this was provided [189]. Hence, the possibility of accom-
modation of two (or more) aromatic molecules simultaneously on the chromophore of
another aromatic molecule is still an open question.
4.3.3. Drug-chlorophylline system
Chlorophylline (CHL) is a water-soluble porphyrin which, of all the porphyrins, has
been studied most systematically in terms of its hetero-association with other aromatic
molecules with the principal goal to get insight into the interceptor properties of
porphyrins.
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The ﬁrst detailed investigation of CHL-drug and related systems was performed
with respect to various mutagen molecules [39, 44, 198–204], and more recent studies
[41, 156, 157, 205, 206] have extended the set of drugs to antitumor antibiotics and
some other types of mutagens. It was found that chlorophylls are able to form face-to-
face complexes with planar molecules, and the addition of methyl groups above or
below the plane of the mutagen molecule interferes sterically with overlapping CHL/
mutagen ring systems, thus reﬂecting the importance of ‘structural complementarity’ in
hetero-association [156]. No clear relationship was observed between Kh and the spe-
ciﬁc number or positions of methyl groups [44]. The presence of a metal ion in the
centre of the CHL chromophore apparently promotes hetero-association, although it is
generally believed that the tetra-pyrrole ring of CHL plays a crucial role in determining
the strength of hetero-association [41, 44]. The equilibrium hetero-association constant,
Kh, in CHL-drug systems was shown to be, on average, two to three orders of magni-
tude higher than that for drug-xanthine systems [39, 44, 201, 205, 206] and these result
have also been supported by calorimetrically measured enthalpies of hetero-association,
giving large negative values in the range −30…−40 kJ/mol [156]; this was explained
in terms of the more extended aromatic system of the CHL chromophore providing
more signiﬁcant van der Waals and hydrophobic contributions to the net energetic
effect of the hetero-association reaction [41, 199, 202, 203]. The order of magnitudes
of Kh was found to correlate with the area of aromatic chromophore of the drugs (i.e.
with the number of fused aromatic rings, see Figure 3). The general conclusion result-
ing from these studies and the related functional activity of CHL both in vivo and
in vitro was that CHL must have higher interceptor ability than the xanthine molecules
with respect to aromatic drugs [206]. Comparison of the ranges of Kh with the drug-
vitamin systems suggests that the interceptor ability of CHL should also be more
pronounced when compared to the aromatic vitamins.
4.4. Hetero-association of aromatic drugs with aromatic mutagens and antibiotics
The suggested biological role of the hetero-association of aromatic antibiotics and caf-
feine has stimulated investigations into the interaction of antitumor antibiotics with
other types of aromatic compounds, in particular, mutagens and antibiotics. All these
molecules typically absorb in the UV and/or visible range of spectrum, which causes a
basic difﬁculty in studying their hetero-association by spectrophotometry. Hence, the
hetero-association of these types of molecules has been mainly performed by NMR
spectroscopy, except for a few cases when reliable decomposition of UV/Vis was
possible (e.g. [207]).
A number of systems have been studied by NMR under similar solution conditions
(0.1 M ionic strength, pH ~7.1): the hetero-association of phenanthridine (EB, PI, ethi-
dium mono- and di-azides) [189, 208–211], acridine (AO, PF) [74, 207] and xanthene
[212] dyes with the antibiotics DAU, TPT and quinolones; the hetero-association of
antitumor antibiotics DAU-NOV [213], DAU-AMD [214, 215], DAU-NOR [168],
DAU-NOG [167, 191], NOV-AMD [214], NOV-NOG [167, 191], NOR-NOG [168],
NOG-AMD [167, 191], DAU-TPT [189], antimalarial drugs [216] and the hetero-associa-
tion of mutagens: AO-PF [217], EB-PI [218], PF-EB [75, 76], dyes [219] and some other
aromatic drug molecules [13, 220]. These molecules have a planar 3- or 4-ring aromatic
chromophore (except the 2-ring NOR molecule) and must potentially be characterised by
greater π-stacking interactions than that provided by the derivatives of nucleic acid bases
and xanthines. The range of reported magnitudes of Kh, enthalpies and entropies
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conﬁrmed this expectation. The general conclusions drawn from analysis of experimental
data followed the pattern already described above for the hetero-association of the deriva-
tives of nucleic acid bases and interceptor molecules, i.e. the predominance of π-stacking
interactions, intermediate with respect to self-association magnitudes of thermodynamic
parameters, large negative values of enthalpy/entropy, systematic magnetic shielding of
aromatic protons in the hetero-complex except when X and Y molecules have signiﬁcantly
different dimensions, e.g. NOR-DAU/NOG [168], resulting in small deshielding of some
protons (the effect already discussed in Section 4.3.1). We can, however, distinguish two
distinctive features of the drug–drug and drug–mutagen systems.
Unlike the derivatives of nucleic acid bases or porphyrins, which have nearly
square-shaped chromophores and so there is some ambiguity in determining the struc-
tures of the 1:1 hetero-complexes from NMR proton shielding and/or molecular model-
ling, the chromophores of aromatic antibiotics and mutagens, listed above, are
composed of linear- or angular-fused 3 or 4 aromatic rings (see Figure 1), which results
in a more reliable determination of the structure of hetero-complexes from analysis of
induced magnetic shielding of aromatic protons of the interacting molecules. The gen-
eral feature of the structures of these 1:1 hetero-complexes is that the chromophores are
always oriented in a way to achieve maximum overlap and no indication of signiﬁ-
cantly twisted or shifted structures was reported. A tilt and shift of the chromophores
was only observed in case of the 1:1 hetero-complexes of antimalarial drugs [216] with
relatively weak 2-ring aromatic system and bulky side chains, creating steric hindrance
to the formation of a compact π-stacked structure. This fact supports the conclusion that
hetero-association is mainly driven by stacking interactions with the major contributions
from hydrophobic and van der Waals interactions. In rare cases, the possibility of
charge-transfer was inferred from ﬂuorescence spectroscopy [207]. In some cases, the
structures of the hetero-complexes appeared to be more compact compared to the
homo-aggregates. For example, in the NOG-AMD and NOG-DAU complexes [167,
191], the twist angle between the chromophores is nearly zero, whereas in their homo-
aggregates it is 10º or higher. These features most likely reﬂect the principle of ‘struc-
tural complementarity’ discussed above for the drug-xanthine systems and act as a ﬁne
tuning of hetero-association based on stacking as a major driving force. Complementar-
ity in hetero-association has also been manifested by slightly smaller distance between
the chromophores in some hetero-complexes (e.g. 0.32 nm in DAU-AMD [214, 215]).
But the most general manifestation of complementarity was the fact that nearly all the
investigated hetero-complexes had structures with maximum separation of bulky side
chains or electric charges on chromophores. In particular, in all combinations of mole-
cules carrying a positive charge (viz. NOG-DAU, AO-PF, EB-PI, PF-EB), the struc-
tures of hetero-complexes were always antiparallel. If, however, the interacting
molecules are non-rigid or contain bulky side chains comparable in their dimension
with the aromatic chromophore, the disruption of the compact π-stacking structure may
occur as was clearly shown in dye–dye hetero-complexes [219]. It is difﬁcult to
ascertain whether in this context the principle of ‘structural complementarity’ must be
supplemented by ‘electrostatic complementarity’ recently introduced for aromatic inter-
actions [36], as differentiation of their inﬂuence on hetero-association is not possible
with the data available. However, there is direct NMR evidence for the formation of
two dimer structures of the antibiotic DAU with either parallel (charges on DAU am-
inosugar are in close proximity to each other) or antiparallel (charges on DAU
aminosugar are well separated) orientations of chromophores [221, 222], which
suggests that electrostatic factor may not be so signiﬁcant in aqueous solution.
International Reviews in Physical Chemistry 29
D
ow
nl
oa
de
d 
by
 [1
34
.11
7.1
0.2
00
] a
t 2
2:1
3 0
5 J
uly
 20
14
 
The second particular property found for some drug–drug and drug–mutagen
systems is observation for thermodynamic parameters of hetero-association (either Kh
and/or ΔHh) that are greater than the corresponding self-association parameters. This
effect was ﬁrst reported for the hetero-association of DAU with acridine dyes [74] and
then was observed for a range of systems, such as DAU-phenanthridine dyes [208–
211], DAU-NOV [213], DAU-AMD [214, 215], FMN-PF/EB [190] and TPT-PF [189].
The effect appeared to be systematic rather than exceptional, as in the case of the het-
ero-association involving interceptor molecules and derivatives of nucleic acid bases
(Sections 4.2 and 4.3). Apart from the increased magnitudes of the thermodynamical
parameters, hetero-association of the majority of the above-cited systems was character-
ised by the existence of intermolecular nOe cross-peaks in 2D NMR spectra, which
were not observed in the corresponding homo-aggregates under similar experimental
conditions. All these facts, plus structural analysis, lead to the conclusion that these het-
ero-complexes of drug–drug, drug–mutagen (and mutagen-vitamin discussed in Sec-
tion 4.3.2) are additionally stabilised by intermolecular H-bonds between NH2 and
C=O groups of the interacting molecules [190, 208–211, 213–215]. Re-investigation of
this conclusion compared to an alternative hypothesis of additional stabilisation via
charge-transfer interactions has conﬁrmed the hypothesis of H-bonding by statistical
analysis of thermodynamical parameters on a large data-set [167, 191], by discovery of
the anticooperative character of hetero-association in case of intermolecular H-bonding
[80], by sequential withdrawal of H-bond donor groups [209], and by recent experi-
mental studies using vibrational spectroscopy [192]. It was found that the fh factor (2),
fh≥ 35% may serve as an indicator of additional stabilisation of hetero-complexes by
H-bond and general conditions for the formation of intermolecular H-bond in hetero-
complexes of aromatic molecules have been formulated [167].
4.5. Hetero-association in three-component systems
Investigations of hetero-association of aromatic molecules so far have dealt with two-
component hetero-association, involving complexation of two different species, X and
Y. The question may be asked whether three- or more-component hetero-associations
may have some chemical or biochemical signiﬁcance? Supporting evidence comes from
the ﬁeld of supramolecular chemistry expanding towards the construction of heteroge-
neous functional supramolecular polymers [64], and studies reporting improvement of
the solubility of various drugs in multi-component systems including cyclodextrins and
explained as being due to formation of triple and higher order complexes in solution
[223, 224]. The following hypothesis was formulated [225]. CAF and NMD molecules
are well known as effective hydrotropes increasing the solubility of aromatic drugs via
the hetero-association mechanism [163, 194–196]. However, their hydrotropic potency
is limited due to their intrinsic ability to self-associate. It was therefore thought that the
mixture CAF + NMD may act as a more potent hydrotropic agent than either CAF or
NMD alone. NMR investigation of the solubilisation of Vitamin B2 in a model three-
component system FMN-CAF-NMD conﬁrmed this hypothesis [225]. It was suggested
that the mechanism of improved solubility was based on optimisation of the interplay
between self-association (disfavouring solubilisation) and hetero-association (favouring
solubilisation). A qualitatively similar mechanism of the interplay between various
types of homo- and hetero-complexes was used to predict the possibility of regulation
of biological activity of anthracycline antibiotics in the presence of riboﬂavin and caf-
feine [226] and improvement of the solubility of NOV +DAU mixture by the addition
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of caffeine [62]. It is concluded that three-component hetero-associations of aromatic
drug molecules may ﬁnd future applications, e.g. in medicinal chemistry.
One issue regarding the three-component systems is worth noting. Although there
are few data on multi-component interactions, these studies carried out in aqueous solu-
tions did not report any synergistic enhancement or weakening of the hetero-complexes
of the X–Y–Z type. It means that any three-component mixture of aromatic molecules
may be described by mass balance equations containing equilibrium constants measured
in separate one- (self-association of X, Y and Z) and two-component (the hetero-associ-
ation of X–Y, X–Z and Y–Z) studies. This statement was veriﬁed by theoretical evalua-
tion of the titration curves in three-component mixture by means of the mass balance
equations with their further comparison against experiment [62, 79, 225, 226], which
led to the important conclusion that the equilibrium self- and hetero-association con-
stants of one- and two-component interactions are transferrable to a multi-component
hetero-association system under the same solution conditions. This conclusion,
however, must be utilised with caution in cases of additional stabilisation of hetero-
complexes by intermolecular H-bonds (see Section 4.4). The formation of H-bonded
hetero-complexes of higher dimensions than dimers may be an intrinsically anticoopera-
tive process [80], which creates some ambiguity in transferring the equilibrium
constants from one-/two-component to multi-component studies.
4.6. Summary of the structure and thermodynamics of hetero-association
Although the large data-set on hetero-association reactions in aqueous solutions has
been accumulated on very different groups of aromatic molecules, mostly from non-
systematic studies, nevertheless some general conclusions can be drawn:
(i) π-stacking appears to be the major driving force in the formation of hetero-
complexes in aqueous solutions, tending to form compact structures with
maximum overlap of aromatic chromophores aligned in parallel or antiparal-
lel. Examples of in-plane hetero-association are known, but should be treated
as exceptions. Partial disruption of π-stacking is commonly observed, if the
aromatic molecules contain bulky side chains.
0
10
20
30
40
50
60
70
0 5 10 15 20
area of overlap, 10-20 m2
|ΔHh |, 
kJ/mol
Figure 5. Dependence of enthalpy change on the area of overlap of the chromophores of
interacting molecules in hetero-complexes (ΔAh). Data taken from [191] (see also Table 1).
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(ii) The principal contributors to π-stacking in hetero-complexes appear to be
van der Waals and hydrophobic interactions, both of which are relatively
unspeciﬁc for aromatic molecules. It was found that the area of overlap of
aromatic chromophores in 1:1 complexes (ΔAh) is a major determinant of
the enthalpy of hetero-association [191]. This property is manifested by a
correlation of ΔHh with ΔAh in Figure 5, whereas the hydrophobic factor
inﬂuences the entropy of hetero-association via change in solvent-accessible
surface area (SASA). Interestingly, the change in entropy on hetero-associa-
tion, ΔSh, does not correlate with the change in SASA (Figure 6), indicat-
ing the paucity of our current understanding of the origin of ΔSh. As a
consequence, the overall stability of hetero-complexes is statistically corre-
lated with van der Waals interactions via the area of overlap. The most
direct manifestation of the above-mentioned correlations is the increase of
Kh on mutual increase of the m and n numbers (reﬂecting the number of
fused aromatic rings in the structure of the interacting molecules) in the
m:n hetero-complexes (Figure 3), and increase of Kh on addition of
hydrophobic groups.
(iii) Fine tuning of the structure of hetero-complexes is determined by two fac-
tors, viz. ‘structural’ and ‘electrostatic’ complementarity of the interacting
molecules within the complex, which cannot be separated based on results
of existing investigations. In fact, the structures and stabilities of the hetero-
complexes of aromatic molecules in each particular case are determined by
an interplay of these complementarities and the tendency to maximise the
area of overlap of chromophores in 1:1 hetero-complexes.
(iv) No speciﬁc synergistic enhancement of hetero-association beyond the dimer
stage has been reported, which results in the conclusion that the equilibrium
self- and hetero-association constants of one- and two-component interac-
tions are transferrable to a multi-component hetero-association system under
the same solution conditions.
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Figure 6. Dependence of entropy change on the change in solvent-accessible surface area
(SASA) on hetero-association. Data taken from [167, 191] and Refs. therein (see also Table 1).
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(v) An interesting feature in the hetero-association of some systems is the addi-
tional stabilisation of hetero-complexes by intermolecular H-bonds which
intuitively may be considered as sterically less probable in π-stacked struc-
tures. Nevertheless, the formation of H-bonds not disrupting stacking has
widely been reported. In these cases, it is questionable whether the equilib-
rium self- and hetero-association constants of one- and two-component
interactions are transferrable to the multi-component hetero-association sys-
tem under the same solution conditions.
(vi) From the investigations reviewed, it is concluded that the contributions of
electrostatic and charge-transfer factors appear to be relatively small in the
thermodynamics of hetero-association in aqueous solutions. This issue is
quite contentious, because papers continue to appear reporting on the
charge-transfer effect (so far based on indirect evidence); this issue is prob-
ably the greatest fundamental problem of hetero-association of aromatic
molecules which needs to be resolved.
(vii) As seen from Figure 7, the hetero-association of aromatic molecules follows
the enthalpy–entropy compensation, well known to date for non-covalent
interactions in aqueous solutions, including the self-association of various
aromatic molecules (e.g. see [21]).
5. Energetics of hetero-association
So far large efforts have been made with the aim of understanding the major factors
governing the π-stacking of aromatic molecules, resulting in recognition of the general
importance of hydrophobic, electrostatic and van der Waals contributions (e.g. for
review see [8, 11, 24, 34, 36, 37, 227]). The problem of ‘energetic composition’ of
π-stacking is, however, currently far from solution, which is, in part, due to the funda-
mental ambiguity of thermodynamic analysis (to be discussed below), making a great
challenge for further studies. The hetero-association of aromatic molecules provides an
excellent model for understanding the nature of π-stacking.
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Figure 7. Enthalpy–entropy compensation in hetero-association. Data taken from [167, 191] and
Refs. therein (see also Table 1).
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5.1. A fundamental problem in the thermodynamic analysis
The wealth of information on the thermodynamics of hetero-complexes summarised
above leads to some understanding of the speciﬁc factors which stabilise or destabilise
the complexes. The experimental data for such analyses are the thermodynamic quanti-
ties ΔGh (or Kh), ΔHh, ΔSh supplemented by molecular modelling. There is, however,
at least one fundamental problem in using these data in thermodynamic analysis, viz.
the physical forces making up the total energies of non-covalent intermolecular interac-
tion are themselves interconnected by the enthalpy–entropy compensation phenomenon
[8, 228] (see also Figure 7). Hence, any assumptions about the interrelation of known
differences between the systems investigated (e.g. structural) and the net thermodynami-
cal parameters may not be valid. In general, for systems that differ in structural proper-
ties and/or electric charge, it is likely that analysis of the experimentally measured total
Gibbs free energies, enthalpies and entropies, may not be meaningful. A common man-
ifestation of this problem with respect to stacking of aromatic molecules in aqueous
solutions in classical thermodynamical analysis is (i) the inability to separate the contri-
bution from van der Waals and hydrophobic forces, (ii) the lack of clarity of the role of
hydration and (iii) contradictory views on the role of electrostatic interactions for aro-
matic–aromatic complexes [229, 230]. The fundamental reason is that it is not possible
to measure independently the contribution of a speciﬁc energy term to the total stacking
energies, and the questions ‘What forces stabilise/destabilise the stacking of aromatic
molecules in solution and what are their relative importance?’ cannot be addressed
unambiguously from analysis of ΔGh, ΔHh, ΔSh. The problems of analysis of thermo-
dynamic parameters can be partly overcome, if the energy term can be deconvoluted,
i.e. parsing the experimentally measured values of ΔGh, ΔHh, ΔSh in terms of speciﬁc
contributions from particular physical factors [8, 231–233]. Then further analysis of the
calculated terms would enable the questions formulated above to be addressed, in order
to fully understand the ‘energetics of hetero-association’.
5.2. Analysis of energetics at the level of Gibbs free energy change
There have been a few reports on the analysis of π-stacking energetics for the group of
aromatic molecules falling within the scope of the current review (e.g. [230, 234–236])
with the most general contribution given in work speciﬁcally dealing with the hetero-
association of aromatic molecules [237].The results, which cover more than 40 self-
and hetero-association systems in aqueous-salt solution, are brieﬂy summarised.
All the known principal contributors to ΔGh may be summarised in the following
expression:
DGtotal ¼ DGvdW þ DGel þ DGhyd þ DGhb þ DGentr; (3)
where the subscript indices of ΔG designate the contribution to the energy in (3) from
van der Waals (vdW), electrostatic (el), hydrophobic forces (hyd), hydrogen bonds (hb)
and speciﬁc factors predominantly of an entropic nature (entr), respectively. The entro-
pic factors include the energy equivalent of the loss of translational and rotational
degrees of freedom, as well as formation of new vibrational modes in hetero-complexes
[238, 239].
Of the ﬁve net contributions to the free energy in Equation (3), it was found that the
hydrophobic contribution dominates for all systems studied (ΔGhyd = −40…−120 kJ/mol)
and is energetically favourable. The net contributions from ‘vdW’ and ‘el’ factors are
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comparable to each other and are relatively small (<25 kJ/mol in absolute value). The
main destabilisation comes from the net effect of hydrogen bonding ΔGhb dominated by
the loss of hydrogen bonds to water, and the loss of degrees of freedom, ΔGentr. The latter
term is dominated by unfavourable contributions from the loss of translational and rota-
tional degrees of freedom, whereas the vibrational contribution is favourable.
The relative unimportance of the ‘vdW’ and ‘hyd’ terms is a surprise but not mean-
ingful because it is a consequence of consideration of the net contribution of these
interactions in Equation (3), composed of the sum of interactions with solvent and
intermolecular solute–solute interactions. Further deconvolution of the ‘vdW’ and ‘el’
terms into solute–solute and solute–solvent interactions makes it possible to carry out a
full analysis of the Gibbs free energies. As examples, the results of such analyses for
four selected molecular systems, including self-association, are given below:
 DAU-DAU [236, 237]: the main stabilisation comes from the ‘vdW’ solute–solute
interaction and, to a lesser extent, from hydrophobic interactions and electrostatic
interaction with solvent. ‘vdW’ interaction with solvent and electrostatic solute–
solute interaction are unfavourable
 PI-PI [236, 237]: the main stabilisation comes from electrostatic interaction with
solvent and, to a lesser extent, about equally from solute–solute ‘vdW’ and
hydrophobic interactions. ‘vdW’ interaction with solvent and the electrostatic
solute–solute interaction are unfavourable.
 CAF-EB [237]: the main stabilisation comes equally from ‘vdW’ solute–solute
interaction and hydrophobic interactions. The ‘vdW’ interaction with solvent is
unfavourable. There is no contribution to the stability of the complex from all types
of electrostatic interactions.
 FMN-EB [237]: The main stabilisation comes from the solute–solute ‘vdW’
interaction and, to a lesser extent, about equally from hydrophobic interactions and
electrostatic solute–solute interaction. The ‘vdW’ and electrostatic interactions with
solvent are unfavourable.
The following general conclusions on the energetics of hetero-association may be
summarised:
(i) the order of stabilising and destabilising factors depends on the molecular
system studied, and may have a ‘vdW’, electrostatic or hydrophobic nature.
The ‘el’ factor depends strongly on the charges of the interacting molecules
and starts to dominate only if they carry double charge; in all other cases
‘vdW’ and ‘hyd’ are the principal contributors to aromatic stacking, in full
agreement with the review of thermodynamic parameters given in Section 4.
The ‘entr’ factor depends relatively weakly on the type of hetero-system stud-
ied, and may be considered as a constant value, to a ﬁrst approximation.
(ii) the relatively small value of the total Gibbs free energy of hetero-association
(|ΔGh|<30 kJ/mol), as well as the net ΔGvdW and ΔGel terms, is the result of
summation of components with large magnitudes but of opposite sign. The
complexation of aromatic molecules is governed by the effect of compensa-
tion of energy contributions at the levels of physical forces (Equation (3))
and solute–solute/solute–solvent interactions. In part, this provides an expla-
nation of why the ‘el’ factor is relatively unimportant in the thermodynamics
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of hetero-association, viz. the solute–solute and solute–solvent energies nearly
compensate one another.
The review of the literature suggests that the energy proﬁle of aromatic stacking is
similar to what is currently known from analysis of the energetics of aromatic ligands
binding with nucleic acids, also governed by stacking interactions (for reviews see
[189, 240–244]).
5.3. Analysis of energetics at the level of enthalpy and entropy change
A consequence of analysis at the level of ΔGh suggests that deconvolution of energetics
at the level of ΔHh and ΔSh should also be undertaken. However, examples of such
analyses for aromatic molecules are scarce in the literature, which creates a challenge
for future studies. Nevertheless, some important correlations are known between
speciﬁc physical factors and the enthalpy/entropy of hetero-association.
General thermodynamics suggests that the ‘vdW’ and ‘el’ factors contribute predomi-
nantly to ΔHh, whereas ΔSh is mainly composed of the ‘hyd’ and ‘entr’ factors. As
reported above (see Sections 4 and 5.2), for singly charged molecules in aqueous solution
the ‘el’ and ‘entr’ factors are of lesser importance than ‘vdW’ and ‘hyd’. Indeed, the cor-
relation of ΔSh with the presence of hydrophobic groups, as well as the correlation of
ΔHh with the area of overlap of aromatic chromophores (responsible, at least, for the sol-
ute–solute ‘vdW’ interactions), has been noted for various hetero-combinations. The
importance of the area of overlap for the magnitude of ΔHh was conﬁrmed for the large
data-set of hetero-associations of aromatic molecules (see Figure 5) and, more generally,
is a manifestation of the well-known dependence of the stability of π-stacking on area size
[11], whereas the ‘hyd’ factor (and, consequently, ΔSh) has long been known to correlate
with changes in solvent-accessible surface area [245, 246]. However, detailed analysis of
energies at the levels of ΔHh and ΔSh is required in order to fully link theoretical
implications and experiment.
6. ‘White spots’ of hetero-association
Information on structure, thermodynamics and energetics does provide some general
understanding of hetero-association for the set of aromatic molecules and experimental
conditions outlined in this review. There remain some gaps in our understanding (white
spots) in the physico-chemical literature, which offer challenges for further experimen-
tal investigations of hetero-association:
 kinetics of hetero-association. Quite a few papers deal with kinetics of hetero-
association (e.g. [100, 202]) or with the inﬂuence of hetero-association on
photo-transformation of the main aromatic drug in the presence of another
aromatic compound (predominantly grouped around the photosensitising proper-
ties of particular compounds of medical interest, such as Riboﬂavin and a few
other drugs (e.g. [131, 247–249])). These results, however, give little insight into
the kinetics of hetero-association;
 the inﬂuence of metal ions on the stability of hetero-complexes may be based on
the intuitive assumption that metal ions enhance the stability of hetero-complexes
by analogy with self-association [17], though information on hetero-complexes is
generally unknown and needs to be investigated;
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 inﬂuence of buffer and other solution parameters. It is generally believed that the
type of buffer in aqueous solution does not signiﬁcantly affect the structural and
thermodynamical parameters of self-association of aromatic molecules, which is
based on several direct or indirect investigations (e.g. [221] and Refs. therein).
No such studies, however, have so far been performed with respect to the hetero-
association. A similar situation is the case with respect to the inﬂuence of pH
and ionic strength on the hetero-association propensity. As discussed above, few
studies on this matter are available in literature (e.g. [159, 220]), which precludes
provision of a general view;
 decomposition of ΔHh and ΔSh into the energy contributions from particular
physical factors. Solution of this task will enable the role of various physical fac-
tors in determining the stability of hetero-complexes to be fully understood.
The list of ‘white spots’ given above is not complete but will be expanded in the
course of further developments in this area.
7. Summary
Although studies of the hetero-association of aromatic molecules have been carried out
over the last 50-year period, the subject as a separate physico-chemical process has
never been systematically reviewed heretofore. The summary in the present review
indicates that there are some important correlations of the ability of aromatic drugs to
form hetero-association aggregates in solution, such as the hetero-association nature of
hydrotropy and the hetero-association mechanism of biological synergism in combina-
tions of aromatic drugs. Knowledge of the physical chemistry of hetero-association is
increasingly important in view of the rapidly emerging branch of supramolecular chem-
istry dealing with the formation of heterogeneous polymeric structures having speciﬁc
functional roles. The review has shown that there are some gaps in our understanding
of hetero-association, which provides a challenge for further studies in this area.
Abbreviations
AMD actinomycin D
ActIII actinocyl-bis(3-dimethylaminopropylamine)
AMP (ADP, ATP) adenosine mono- (di-, tri-) phosphate
AO acridine orange
BC betacarbolines
CAF caffeine
CHL chlorophylline
DAPI 4′,6-diamidino-2-phenyl-indole
DAU daunomycin
DiMeIQx 2-amino-trimethylimidazo[4,5-f] quinoxaline)
DOX doxorubicin
EB ethidium bromide
EMB (EDC) ethidium mono- (di-) azide
FL ﬂuorescence
FMN ﬂavin mononucleotide
FN ﬂavin family
Glu-P-1 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole
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Glu-P-2 2-aminodipyrido[1,2-a:3′,2′-d]imidazole H2TTMePP - 5,10,15,20-
tetrakis[4-(trimethylammonio)-phenyl]porphine
H2TMePyP 5,10,15,20-tetrakis(1-methyl-4-pyridyl)porphine
H2TCPP 4,4′,4″,4″′-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-(benzoic
acid)
H2TPPS4 5,10,15,20-tetrakis(4-sulfonatophenyl)-porphine
HAL halofantrine
ICR-170 1,3,7-propanediamine-N-(2-chloroethyl)-N-(6-chloro-2-methoxy-
9-acridinyl)-N-ethyl
ICR-191 2-methoxy-6-chloro-9-(3-(2-chloroethyl)aminopropylamino)
acridine
IQ imidazoquinoline-type aromatic amines
IQx 2-amino-3-methylimidazo[4,5-f]quinoxaline
MAO monoaminooxidase
MB methylene blue
MC microcalorimetry
MeIQ 2-amino-3,4-dimethylimidazo[4,5-f]quinoline
MeIQx 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
NAD nicotinamide adenine dinucleotide
NAS sodium salicylate
NMD nicotinamide
NMR nuclear magnetic resonance
NO2IQ 2-nitro-3-methylimidazol[4,5-f]quinoline
NOG nogalamycin
NOR norﬂoxacin
NOV novantrone (or mitoxantrone)
OSM osmometry
PF proﬂavin
PhIP 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
PI propidium iodide
PRT partition studies in water–octanol mixture
PTX pentoxifylline
QM quinacrine mustard
RBF riboﬂavin
SASA solvent-accessible surface area
THB theobromine
THP theophylline
THP7AA (PA, BA) theophylline-7-acetic acid (propionic acid, buturic acid)
SOL solubility studies
SP absorption spectrophotometry
TPT topotecan
TriMeIQx 2-amino-3,4,7,8-tetramethylimidazo[4,5-f]quinoxaline
Trp-P-1 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole
Trp-P-2 3-amino-1-methyl-5H-pyrido[4,3-b]-indole
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